Commissioner Scott Gottlieb said Monday the FDA plans to use funding expected to be soon approved by Congress to modernize generic drug reviews and enable the agency to take a more active role in updating generic drug labels when a branded drug has been withdrawn.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,